DMD Therapeutics Inc.
2032 41st Avenue E
About DMD Therapeutics Inc.
DMD Therapeutics Inc. is a privately held corporation registered in Delaware. The Company was founded by Carlo Rago, PhD and Ron Berenson, MD in 2016 to develop novel therapeutics for DMD and other muscular dystrophies.
Founders: Ron Berenson and Carlo Rago
Founder and CEO: Ron Berenson
Founder and CSO: Carlo Rago
4 articles with DMD Therapeutics Inc.
DMD Therapeutics is based in Seattle, although at present it is a virtual company, and, as its name suggests, is focused on developing therapeutics for DMD.
BioSpace is proud to present its NextGen "Class of 2018," a list of 20 up-and-coming life science companies in North America that started up no earlier than 2015.
DMD Therapeutics Receives Funding From DMD Foundations To Develop DMD-813 For Treatment Of Duchenne Muscular Dystrophy